Sipai Health Technology (314) Stock Overview
Operates as a medical technology and health management company in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
314 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sipai Health Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.24 |
| 52 Week High | HK$7.38 |
| 52 Week Low | HK$2.98 |
| Beta | -0.87 |
| 1 Month Change | -38.29% |
| 3 Month Change | -32.36% |
| 1 Year Change | -46.00% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.04% |
Recent News & Updates
Sipai Health Technology Co., Ltd.'s (HKG:314) Shares Climb 25% But Its Business Is Yet to Catch Up
Aug 04
We Think Sipai Health Technology (HKG:314) Can Easily Afford To Drive Business Growth
Jul 18Recent updates
Sipai Health Technology Co., Ltd.'s (HKG:314) Shares Climb 25% But Its Business Is Yet to Catch Up
Aug 04We Think Sipai Health Technology (HKG:314) Can Easily Afford To Drive Business Growth
Jul 18Investors Appear Satisfied With Sipai Health Technology Co., Ltd.'s (HKG:314) Prospects As Shares Rocket 31%
Jun 18Sipai Health Technology Co., Ltd.'s (HKG:314) 32% Cheaper Price Remains In Tune With Revenues
Apr 18Why We're Not Concerned About Sipai Health Technology Co., Ltd.'s (HKG:314) Share Price
Jun 08Here's Why We're Not At All Concerned With Sipai Health Technology's (HKG:314) Cash Burn Situation
Feb 14Sipai Health Technology Co., Ltd.'s (HKG:314) 66% Price Boost Is Out Of Tune With Revenues
Apr 17Sipai Health Technology (HKG:314) Is In A Strong Position To Grow Its Business
Mar 24Shareholder Returns
| 314 | HK Consumer Retailing | HK Market | |
|---|---|---|---|
| 7D | 2.5% | 3.2% | 2.9% |
| 1Y | -46.0% | 35.3% | 20.7% |
Return vs Industry: 314 underperformed the Hong Kong Consumer Retailing industry which returned 35.3% over the past year.
Return vs Market: 314 underperformed the Hong Kong Market which returned 20.7% over the past year.
Price Volatility
| 314 volatility | |
|---|---|
| 314 Average Weekly Movement | 9.4% |
| Consumer Retailing Industry Average Movement | 7.9% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.8% |
| 10% least volatile stocks in HK Market | 3.4% |
Stable Share Price: 314 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 314's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 2,950 | Xuguang Ma | www.medbankshealthtech.com |
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People’s Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment provides specialty pharmacies and value-added professional pharmacist services; focuses on innovative medicines for the treatment of oncology; pharmaceutical supply chain network for health insurance services; and other critical illnesses.
Sipai Health Technology Co., Ltd. Fundamentals Summary
| 314 fundamental statistics | |
|---|---|
| Market cap | HK$2.43b |
| Earnings (TTM) | -HK$347.01m |
| Revenue (TTM) | HK$3.74b |
Is 314 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 314 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.43b |
| Cost of Revenue | CN¥3.09b |
| Gross Profit | CN¥332.69m |
| Other Expenses | CN¥650.21m |
| Earnings | -CN¥317.52m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.42 |
| Gross Margin | 9.71% |
| Net Profit Margin | -9.27% |
| Debt/Equity Ratio | 0% |
How did 314 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/04 12:11 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sipai Health Technology Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhu Chen | Citic Securities Co., Ltd. |
| Kehan Meng | Haitong International Research Limited |
| Youjue Hu | Morgan Stanley |